Search Results - "Hallström, Yngve"

Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials by Tepper, Stewart J, Ashina, Messoud, Reuter, Uwe, Hallström, Yngve, Broessner, Gregor, Bonner, Jo H, Picard, Hernan, Cheng, Sunfa, Chou, Denise E, Zhang, Feng, Klatt, Jan, Mikol, Daniel D

“…Background In patients with migraine, overuse of acute medication, including migraine-specific medication (MSM) such as triptans and ergots, can lead to…”
Get full text

A Controlled Trial of Erenumab for Episodic Migraine by Goadsby, Peter J, Reuter, Uwe, Hallström, Yngve, Broessner, Gregor, Bonner, Jo H, Zhang, Feng, Sapra, Sandhya, Picard, Hernan, Mikol, Daniel D, Lenz, Robert A

“…The monoclonal antibody against CGRP receptor, erenumab, administered subcutaneously once a month, significantly reduced migraine frequency by approximately 2…”
Get full text

Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension by Oertel, Wolfgang H., Hallström, Yngve, Saletu-Zyhlarz, Gerda M., Hopp, Michael, Bosse, Björn, Trenkwalder, Claudia

“…Objective The aim was to assess the effects of prolonged release oxycodone/naloxone (OXN PR) on sleep and quality of life (QoL) in patients with severe…”
Get full text

Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab by Buse, Dawn C, Lipton, Richard B, Hallström, Yngve, Reuter, Uwe, Tepper, Stewart J, Zhang, Feng, Sapra, Sandhya, Picard, Hernan, Mikol, Daniel D, Lenz, Robert A

“…Background We evaluated the effect of erenumab, a fully human monoclonal antibody that inhibits the canonical calcitonin gene-related peptide receptor, on…”
Get more information

The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response by Broessner, Gregor, Reuter, Uwe, Bonner, Jo H., Dodick, David W., Hallström, Yngve, Picard, Hernan, Zhang, Feng, Lenz, Robert A., Klatt, Jan, Mikol, Daniel D.

“…Objective To assess the efficacy of erenumab at the ≥50%, ≥75%, and 100% reduction in monthly migraine days (MMD) response thresholds, using data from the…”
Get full text

KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy by Trinka, Eugen, Marson, Anthony G, Van Paesschen, Wim, Kälviäinen, Reetta, Marovac, Jacqueline, Duncan, Benjamin, Buyle, Sonja, Hallström, Yngve, Hon, Petr, Muscas, Gian Carlo, Newton, Mark, Meencke, Heinz-Joachim, Smith, Philip E, Pohlmann-Eden, Bernd

“…Objective To compare the effectiveness of levetiracetam (LEV) with extended-release sodium valproate (VPA-ER) and controlled-release carbamazepine (CBZ-CR) as…”
Get full text

Efficacy of pramipexole in restless legs syndrome: A six-week, multicenter, randomized, double-blind study (effect-RLS study) by Oertel, Wolfgang H., Stiasny-Kolster, Karin, Bergtholdt, Bettina, Hallström, Yngve, Albo, Jaan, Leissner, Lena, Schindler, Thomas, Koester, Juergen, Reess, Juergen

“…We evaluated the efficacy of pramipexole versus placebo in restless legs syndrome (RLS) for 6 weeks. Overall, 345 patients were randomly assigned in a 1:2…”
Get full text

One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study by Goadsby, Peter J., Reuter, Uwe, Hallström, Yngve, Broessner, Gregor, Bonner, Jo H., Zhang, Feng, Wright, Ian K., Chou, Denise E., Klatt, Jan, Picard, Hernan, Lenz, Robert A., Mikol, Daniel D.

“…OBJECTIVETo assess efficacy and tolerability of 1-year erenumab treatment in patients with episodic migraine. METHODSPatients were randomized (n = 955; 1:1:1)…”
Get full text

Sustained Efficacy Over 1 Year of Treatment With Erenumab: Results From the Extension Phase of the STRIVE Study in Episodic Migraine (S38.005) by Chou, Denise E., Goadsby, Peter J., Reuter, Uwe, Hallström, Yngve, Broessner, Gregor, Bonner, Jo H., Zhang, Feng, Sapra, Sandhya, Klatt, Jan, Picard, Hernan, Mikol, Daniel D.

“…Abstract only…”
Get full text

Use of Acute Headache and Migraine Medications in Patients with Episodic Migraine in the STRIVE Phase 3 Trial of Erenumab for Migraine Prevention (P4.118) by Reuter, Uwe, Bonner, Jo, Broessner, Gregor, Hallstrom, Yngve, Picard, Hernan, Cheng, Sunfa, Zhang, Feng, Mikol, Daniel, Klatt, Jan

“…Abstract only…”
Get full text

Phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab (amg 334) in migraine prevention: primary results of the strive trial by Goadsby, Peter J, Reuter, Uwe, Bonner, Jo, Broessner, Gregor, Hallstrom, Yngve, Zhang, Feng, Sapra, Sandhya, Picard, Hernan, Mikol, Daniel, Lenz, Robert

“…ObjectivesTo evaluate the efficacy and safety/tolerability of erenumab (AMG 334) in a phase 3 trial of subjects with episodic migraine (EM)…”
Get full text

Distribution of lumbar spinal evoked potentials and their correlation with stimulation-induced paresthesiae by Hallström, Y T, Lindblom, U, Meyerson, B A

“…In 7 awake patients with neuropathic lower extremity pain, spinal somatosensory evoked potentials (SEP) were elicited from the non-painful leg by electrical…”
Get more information

Epidurally recorded cervical spinal activity evoked by electrical and mechanical stimulation in pain patients by Hallström, Y T, Lindblom, U, Meyerson, B A, Prevec, T S

“…Spinal SEPs to electrical and mechanical stimulation of the upper limb of the non-painful side in 7 pain patients were recorded from the cervical epidural…”
Get more information